Log In
BCIQ
Print this Print this
 

JTT-851

  Manage Alerts
Collapse Summary General Information
Company Japan Tobacco Inc.
DescriptionOral G protein-coupled receptor 40 (GPR40) agonist
Molecular Target Free fatty acid receptor 1 (FFAR1) (GPR40)
Mechanism of ActionG protein-coupled receptor 40 (GPR40) agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation
PartnerTorii Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today